A MESSAGE TO READERS
NCI Cancer Bulletin Suspends Publication
Featured clinical trials and summaries highlighting recent results from cancer clinical trials will continue to be published on cancer.gov. Cancer research news and information are also available through NCI’s social media channels on Twitter, Facebook, and YouTube.
Please feel free to send your comments to firstname.lastname@example.org.
Researchers have identified a genetic variant that is strongly associated with the ability to spontaneously clear infection with the hepatitis C virus (HCV) and with the response to treatment for chronic HCV infection, the leading cause of liver cancer in the United States.
And, in a surprising finding, the discovery of the variant led to the first identification of a previously unknown gene, IFNL4. The variant in this gene is directly responsible for the creation of a newly identified protein, called Interferon Lambda 4 (IFNL4), from the interferon lambda family of proteins. Read more > >
- New Videos from NCI: "Understanding Your Cancer Prognosis"
- In Memoriam: Dr. Elwood V. Jensen
- NCI Central Institutional Review Board Receives Accreditation
- Cyber-Seminar: Using State Cancer Profiles for Cancer Control
- Summary of NCI Funding Patterns for FY2012 Available
The director of NCI's Division of Cancer Prevention and editor-in-chief of NCI's Physician Data Query Screening and Prevention Editorial Board talks with NIH Research Radio about cancer screening and the risks that are sometimes associated with it.
Type: (MP3) | Time 8:53 | Size: 10.1 MB | Read Transcipt
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at email@example.com.